Wilson Sonsini Goodrich & Rosati advised OneSkin on intellectual property matters related to the transaction. OneSkin, a biotech skin health brand, announced the completion of an...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Magenta Medical (Magenta) announced that it has raised $105 million in financing. The financing was...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Genoa Ventures on patent matters related to the transaction. Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, announced it...
You must be a Standard 1 Year member to access this content.
DORDA, Kromann Reumert and Linklaters advised Novo Holdings A/S on the transaction. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on IP Matters. Novo Holdings A/S...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Foresight Diagnostics on the transaction. Allogene Therapeutics Inc. (Nasdaq: ALLO) and Foresight Diagnostics, announced a strategic partnership to develop a minimal residual...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is advising Arcellx on the transaction. Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD) announced that they have...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
You must be a Standard 1 Year member to access this content.
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Foresight on the deal. Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced the close of an...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised EVERY on the deal while Pillsbury Winthrop Shaw Pittman represented McWin. The EVERY Company, the leading precision fermentation platform accelerating a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Hexagon Bio on the deal. Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome,...
You must be a Standard 1 Year member to access this content.
